Ledger.Open graph →
SEC Form D · filed February 2, 2022

Hopewell Therapeutics, Inc

Offering
$7.1M
Sold
$7.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WOBURN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Xutian V. Jing · WOBURN, MADirectorThomas V. Hennessey · WOBURN, MADirectorJake V. Xia · WOBURN, MADirectorQiaobing Xu · Lexington, MAExec · DirectorHoward V. Rosen · WOBURN, MADirectorXutian V. Jing · WOBURN, MADirectorThomas V. Hennessey · WOBURN, MADirectorJake V. Xia · WOBURN, MADirectorQiaobing Xu · Lexington, MAExec · DirectorHoward V. Rosen · WOBURN, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗